Código QR (código de barras bidimensional)

Valvular Heart Disease Interventional Trials From 2000 to 2024

Background: Valvular heart disease (VHD) is a growing contributor to global cardiovascular morbidity, especially in aging populations. As transcatheter therapies expand, assessing enrollment trends and demographic representation is essential for equitable, generalizable evidence. Objectives: The pur...

תיאור מלא

שמור ב:
Principais autores: Frederick Berro Rivera, MD, Chieh-Mei Tsai, MD, Polyn Luz S. Pine, MD, MBA, Nicole Tesoro, MD, John Vincent Magalong, MD, Nathan Ross B. Bantayan, BSc, Christine J. Lin, BA, Gabriel A. Tangco, MD, MBA, Abdullah Al-Abcha, MD, Mandeep Singh, MD, Mayra Guerrero, MD
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2026-01-01
סדרה:JACC: Advances
נושאים:
clinical trials
enrollment
sex disparities
trend
valvular heart disease
גישה מקוונת:http://www.sciencedirect.com/science/article/pii/S2772963X25008142
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים